Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Run‑Qiang Chen"'
Autor:
Jiing-Dwan Lee, John R. Yates, Colleen Fearns, Yan-ling Chen, Greg Cantin, Wei Yi, Bing-wen Lu, Qing-kai Yang, Run-qiang Chen
Supplementary Figure Legend from CDC25B Mediates Rapamycin-Induced Oncogenic Responses in Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a916e4322ea88eef979f662d1378038
https://doi.org/10.1158/0008-5472.22380917.v1
https://doi.org/10.1158/0008-5472.22380917.v1
Autor:
Jiing-Dwan Lee, John R. Yates, Colleen Fearns, Yan-ling Chen, Greg Cantin, Wei Yi, Bing-wen Lu, Qing-kai Yang, Run-qiang Chen
Supplementary Figure 1 from CDC25B Mediates Rapamycin-Induced Oncogenic Responses in Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88021e5ed25cd14e4174860328dc9d78
https://doi.org/10.1158/0008-5472.22380920
https://doi.org/10.1158/0008-5472.22380920
Autor:
Jiing-Dwan Lee, John R. Yates, Colleen Fearns, Yan-ling Chen, Greg Cantin, Wei Yi, Bing-wen Lu, Qing-kai Yang, Run-qiang Chen
Because the mammalian target of rapamycin (mTOR) pathway is commonly deregulated in human cancer, mTOR inhibitors, rapamycin and its derivatives, are being actively tested in cancer clinical trials. Clinical updates indicate that the anticancer effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5da08f3f214e29e58f984a8e4afea7a9
https://doi.org/10.1158/0008-5472.c.6499709.v1
https://doi.org/10.1158/0008-5472.c.6499709.v1
Autor:
Jiing-Dwan Lee, John R. Yates, Colleen Fearns, Yan-ling Chen, Greg Cantin, Wei Yi, Bing-wen Lu, Qing-kai Yang, Run-qiang Chen
Supplementary Table 1 from CDC25B Mediates Rapamycin-Induced Oncogenic Responses in Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206eee97049c3a56858d7a4cc5ee23e4
https://doi.org/10.1158/0008-5472.22380914.v1
https://doi.org/10.1158/0008-5472.22380914.v1
Autor:
Jiing-Dwan Lee, John R. Yates, Colleen Fearns, Yan-ling Chen, Greg Cantin, Wei Yi, Bing-wen Lu, Qing-kai Yang, Run-qiang Chen
Supplementary Table 2 from CDC25B Mediates Rapamycin-Induced Oncogenic Responses in Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1953fb4d6f4076659f2bbaac3629352e
https://doi.org/10.1158/0008-5472.22380911.v1
https://doi.org/10.1158/0008-5472.22380911.v1
Autor:
Mu Chen, Run-Qiang Chen, Yuan Guo, Jian-Xin Chen, Qian Jin, Mei-Hong Chen, Bo-Yong Chen, Zheng-Chao Tu, Wen-Cai Ye, Lei Wang
Publikováno v:
Phytochemistry. 211:113699
Autor:
Cai‑Rong Chen, Xiao‑Yan Guo, Xiao‑Yue Zhang, Qiu‑Xia Yan, Run‑Qiang Chen, Zhi‑Ming Cai, Ai‑Fa Tang
Publikováno v:
Oncology Letters
The majority of bladder cancer-associated mortalities are due to transitional cell carcinoma (TCC), which is the most prevalent and chemoresistant malignancy of the bladder. Sperm acrosome associated 5 (SPACA5)/Spaca5 is a sperm acrosome-associated,
Autor:
Run-qiang Chen, John R. Yates, Xianming Deng, Lujian Liao, Qingkai Yang, Jiing Dwan Lee, Nathanael S. Gray
Publikováno v:
Oncogene
Promyelocytic leukemia protein (PML) modulates the p53 tumor suppressor through its interaction with p53 and MDM2. We found that activated big MAP kinase 1 (BMK1) preferentially associates with PML isoform IV and disrupts PML-MDM2 interaction. Doxoru
Publikováno v:
Advanced Materials Research. :1278-1283
In our real estate enterprises, the rapid growth and lopsided organization structure have become the obstacle for the development. This paper regards real estate enterprise as the research object. Based on the foundation of substantive investigation
Autor:
Jiing Dwan Lee, Colleen Fearns, Run-qiang Chen, Vasco A. Oliveira, William S. Dalton, Yan-ling Chen, Qingkai Yang
Publikováno v:
The Journal of Biological Chemistry
Hypoxia-inducible factor-1 (HIF-1) plays a central role in tumor progression by regulating genes involved in proliferation, glycolysis, angiogenesis, and metastasis. To improve our understanding of HIF-1 regulation by kinome, we screened a kinase-spe